Research Article
[Retracted] Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis
Table 3
Multivariate analysis of influencing patients' overall survival.
| | B | Se | Wald | Df | Sig. | Exp (B) | 95.0% CI exp (B) | Down | Up |
| Gender | −0.628 | 0.465 | 1.824 | 1 | 0.177 | 0.534 | 0.215 | 1.327 | Age | −0.132 | 0.473 | 0.077 | 1 | 0.781 | 0.877 | 0.347 | 2.217 | Number of bone metastases | 0.570 | 0.629 | 0.823 | 1 | 0.364 | 1.769 | 0.516 | 6.065 | ECOG scores | −1.085 | 0.692 | 2.455 | 1 | 0.117 | 0.338 | 0.087 | 1.313 | Chemotherapy | 0.805 | 0.502 | 2.569 | 1 | 0.109 | 2.236 | 0.836 | 5.982 | Visceral metastasis | −0.983 | 0.737 | 1.777 | 1 | 0.182 | 0.374 | 0.088 | 1.587 | CX3CL1 | −1.264 | 0.627 | 4.067 | 1 | 0.044 | 0.283 | 0.083 | 0.965 | CCL28 | −1.621 | 0.901 | 3.235 | 1 | 0.072 | 0.198 | 0.034 | 1.156 |
|
|
P<0.05; OS, overall survival; HR, hazard ratio; 95% CI, 95% confidence interval. |